Home » Authors » Cormac Sheridan

Articles by Cormac Sheridan

Focused On Drug Development, BioInvent In-Licenses Program

Oct. 29, 2003

By Cormac Sheridan

Denmark OKs Its First Human Embryonic Stem Cell Program

Oct. 22, 2003

By Cormac Sheridan

Denmark OKs Its First Human Embryonic Stem Cell Program

Oct. 22, 2003

By Cormac Sheridan

Nuevolution Raises $15M To Develop Compound Libraries

Oct. 15, 2003

By Cormac Sheridan

Pyrosequencing Paying Dyax $35M For Biotage Subsidiary

Oct. 15, 2003

By Cormac Sheridan

Pyrosequencing Paying Dyax $35M For Biotage Subsidiary

Oct. 15, 2003

By Cormac Sheridan

Nuevolution Raises $15M To Develop Compound Libraries

Oct. 15, 2003

By Cormac Sheridan

TiGenix First Round Raises EUR12M For Cartilage Repair Phase III Trial

Oct. 8, 2003

By Cormac Sheridan

Genzyme Looking To Raise Scientific Profile In Europe

Oct. 8, 2003

By Cormac Sheridan

TiGenix First Round Raises EUR12M For Cartilage Repair Phase III Trial

Oct. 8, 2003

By Cormac Sheridan

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Nov. 25, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for November 25, 2024.
J&J’s Ottava robotic system approved for US pivotal trial
BioWorld MedTech
Johnson & Johnson received U.S. FDA investigational device exemption to begin the pivotal clinical trial for the Ottava robotic surgical system. If the trial goes...
‘Evo’ AI can design complete genomes
BioWorld Science
The development of new machine learning tools like Alphafold and Rfdiffusion has allowed scientists to predict the structure of proteins and design them for drug...
Apollo signs near-$1B deal for Sunshine’s FGF21/GLP-1 injection
BioWorld Asia
Apollo Therapeutics Group Ltd. and Sunshine Lake Pharma Co. Ltd. inked a potential $938 million licensing deal for APL-18881 (HEC-88473), Sunshine’s dual...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.